Allergen, Individual-Tree pollen Willow Salix Caprea T12

The Allergen, Individual-Tree pollen Willow Salix Caprea T12 is an at‑home diagnostic that detects willow (Salix caprea) pollen sensitization by measuring specific IgE antibodies using validated laboratory immunoassays. It provides quantitative results (kU/L) with a clear positive/negative classification and semiquantitative classes to inform clinical interpretation. The test can be performed from a capillary finger‑prick or venous sample collected at home or by a licensed phlebotomist, delivering lab-grade accuracy to guide avoidance strategies, symptom management, and decisions about allergen immunotherapy. Results are issued by accredited UAE laboratories and can be shared directly with treating clinicians across Dubai for timely follow-up.

• Salix caprea (Willow) pollen-specific IgE
• Specific IgE concentration (kU/L)
• Result classification (Class 0–6)
• Qualitative sensitization (Positive / Negative)

• Seasonal rhinitis or itchy/watery eyes occurring during tree pollen season
• Suspected pollen-triggered asthma exacerbations in spring
• Prior to initiating tree-pollen allergen immunotherapy
• Persistent symptoms despite antihistamine or nasal steroid use
• Assessment before moving or spending extended time in pollen-prone areas

• Accurate, lab-standard measurement of willow pollen sensitization
• At‑home sample collection or technician visit available across Dubai
• Actionable results to guide avoidance, medication, and referral
• Supports informed decision-making about allergen immunotherapy
• Reported by accredited UAE laboratories for clinician review

• Capillary (finger‑prick) blood collection at home or venous draw by phlebotomist
• No fasting required; continue most regular medications unless advised
• Notify provider of recent biologic therapies (e.g., anti‑IgE) or immunosuppressants
• Provide valid UAE ID and relevant clinical history for accurate reporting